The Market Reports

Synopsis
The global market for Pre-Sterilized Syringe was estimated to be worth US$ 4548 million in 2024 and is forecast to a readjusted size of US$ 6492 million by 2031 with a CAGR of 5.8% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pre-Sterilized Syringe cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Pre-Sterilized Syringe, also called as Pre-filled Syringe, which integrates "storage medicine" and "injection function" into one. Practical and new injection forms are mainly used in vaccines and non-terminally sterilized biological agents.
The Pre-Sterilized Syringe industry concentration is not high; there are more than one hundreds manufacturers in the world, and high-end products mainly from U.S. and Western European.
Global giant manufactures mainly distributed in U.S. and E.U. The manufacturers in U.S. have a long history and unshakable status in this field. Manufacturers such as BD have relative higher level of product’s quality. In Germany, Gerresheimer leads the technology development, it is the world’s second largest player and the No.1 players in Europe. Most of Chinese manufactures locate in Shandong province.
Many companies have several plants, usually locate in the place close to aimed consumption region.
The key consumption markets locate at developed countries. The North America takes the market share of 43.4%, followed by Europe with 28.0%. Asia-Pacific’s consumption market has a quicker growing speed of in the past few years.
This report aims to provide a comprehensive presentation of the global market for Pre-Sterilized Syringe, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pre-Sterilized Syringe by region & country, by Type, and by Application.
The Pre-Sterilized Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pre-Sterilized Syringe.
Market Segmentation
By Company
BD
Gerresheimer
Nipro Corporation
Schott
Stevanato
Simtra (Baxter)
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
J.O.Pharma
West Pharma
Weigao Group
Shandong Zibo Minkang
Shandong Pharmaceutical Glass
Ningbo Zhengli
Shandong Ujoin
Segment by Type
Glass Type
Plastic Type
Segment by Application
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other (Beauty, etc.)
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pre-Sterilized Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pre-Sterilized Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pre-Sterilized Syringe in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index